dacarbazine and its Impurities
Dacarbazine was approved for medical use in the United States in 1975. It is also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma.. Reference standards of Dacarbazine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below